Skip to content

Planned Semi-Elective Lung Transplantation Using 10C Cold Static Preservation

Planned Semi-Elective Lung Transplantation Using 10C Cold Static Preservation: A Proof-of-Concept Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04568694
Enrollment
1
Registered
2020-09-29
Start date
2020-11-30
Completion date
2021-12-03
Last updated
2022-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Disease

Brief summary

This is a prospective, single-arm study to demonstrate the proof-of-concept of semi-elective lung transplantation. We plan to evaluate 15 patients that receive lung(s) delayed for transplantation under our study criteria.

Interventions

PROCEDUREDelayed Lung Transplantation

Transplants with a planned recipient anesthesia start time between 10:00 pm and 6:00 am will be allowed to move to a start time between 6:00 am and 8:00 am at the earliest. Donor lung(s) cross clamp time must occur between 5:00 pm and 4:00 am. Lungs that meet criteria will be transported in the usual fashion in a cooler of ice at 4oC. Upon arrival to NYULH, the lungs will be transferred to cold static preservation at 10oC within a specific incubator located in a NYULH OR (MYTEMP™65HC, Benchmark Scientific).

PROCEDUREConventional Lung Transplantation

Reference Therapy

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Recipient is ≥ 18 years old * Recipient, or their Legally Authorized Representative is able and willing to sign informed consent * Recipient meets standard listing criteria for lung transplantation

Exclusion criteria

* Donor lungs meet criteria for transplantation with ex vivo lung perfusion (EVLP) * Recipient is \< 18 years old * Recipient, or their Legally Authorized Representative is unable to sign informed consent for re-transplantation * Recipient has any condition that, in the opinion of the Investigator, would make study participation unsafe or would interfere with the objectives of the study

Design outcomes

Primary

MeasureTime frameDescription
Incidence of ISHLT primary graft dysfunction grade 3 at 72 hours post-transplant72 hoursAs defined by International Society of Heart and Lung Transplantation (ISHLT)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026